EUVIMEDEUVIMED entdecken
Crossref

A liquid chromatography–tandem mass spectrometry method development for the quantification of favipiravir drug and its related impurities in rat plasma and its application to pharmacokinetic studies

Kalyani Koganti, Namburi L A Amara Babu, Naga Raju Sattu, Koya Prabhakara Rao iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Kalyani Koganti und 3 weiteren Autor:innen. Beteiligte Einrichtung: New Generation Materials Lab, Department of Chemistry, School of Applied Science and Humanities, Vignan's Foundation for Science Technology and Resea…. Hauptthemen laut MEDLINE: Pandemics, Tandem Mass Spectrometry, Amides, Pyrazines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Favipiravir is an antiviral drug used for the treatment of virus‐based diseases such as influenza. In this context, the development of a reliable liquid chromatography–tandem mass spectrometry method for the quantification of the drug and its impurities is necessary, particularly following the COVID‐19 pandemic. Chromatographic separation was achieved on an inertial ODS column using gradient elution with a buffer containing triethylamine in high‐performance liquid chromatography water and adjusting its pH with formic acid. The mixture of buffer and acetonitrile was used as a mobile phase with a flow rate of 1 ml/min at ambient temperature. The separation of favipiravir and its related impurities from remdesivir as an internal standard was achieved. The results indicated that all the variables, like precision, accuracy, linearity, matrix effect and stability, were successfully achieved within the limits of US Food and Drug Administration guidelines. This study could provide a new protocol for the development of new analytical methods for the detection of favipiravir and its impurities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PandemicsTandem Mass SpectrometryAmidesPyrazinesUnited StatesAnimalsRatsHumansPharmaceutical PreparationsChromatography, Liquid

Stichwörter der Autor:innen

LC-MS/MS analytical methodfavipiravirpharmacokinetic studiesrat plasmarelated impurities

Substanzen

Pharmaceutical PreparationsfavipiravirAmidesPyrazines

Autor:innen und Institutionen

  • New Generation Materials Lab, Department of Chemistry, School of Applied Science and Humanities, Vignan's Foundation for Science Technology and Research (Deemed to be University), Guntur, Andhra Pradesh, India.
  • MSN Laboratories Pvt Limited, Sangareddy (District), Telangana, India.
  • Syngene International Ltd., Bangalore, Karnataka, India.
  • Aurobindo Pharma Limited, Medak (District), Telangana, India.

ORCID-Profile: Koya Prabhakara Rao

Zitieren

APA

Koganti, K., Amara Babu, N. L. A., Sattu, N. R., & Rao, K. P. (2024). A liquid chromatography–tandem mass spectrometry method development for the quantification of favipiravir drug and its related impurities in rat plasma and its application to pharmacokinetic studies. Biomedical Chromatography. https://doi.org/10.1002/bmc.5816

Vancouver

Koganti K, Amara Babu NLA, Sattu NR, Rao KP. A liquid chromatography–tandem mass spectrometry method development for the quantification of favipiravir drug and its related impurities in rat plasma and its application to pharmacokinetic studies. Biomedical Chromatography. 2024. doi:10.1002/bmc.5816

BibTeX
@article{Koganti2024,
  author = {Koganti, Kalyani and Amara Babu, Namburi L A and Sattu, Naga Raju and Rao, Koya Prabhakara},
  title = {A liquid chromatography–tandem mass spectrometry method development for the quantification of favipiravir drug and its related impurities in rat plasma and its application to pharmacokinetic studies},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5816}
}
Kostenlos starten →